As a result of the project, the consortium have submitted a proposal to ERASMUS+ for the design of a Erasmus Mundus Joint Master´s Degree in Innovative Pharmacy (INNOPHAR), that develops specialization in advanced therapies, patient centered care and new nanotechnologies for drug delivery. Hopefully, the master will be implemented in 2024.